Health2047, the innovation subsidiary of the American Medical Association, has launched a startup that develops augmented intelligence technologies to support clinical decision making.

Called RecoverX, the startup creates technologies that leverage research, medical charts, patient conversations and test results to provide evidence-based clinical insights and suggested actions for clinicians in real time.

For example, one of the technologies on the core RecoverX platform, called Diagnostic Glass, provides decision-making support to clinicians in more than 30 specialties.